CXCL9 [35] and CXCL10 [36] can effectively inhibit angiogenesis, enhance apoptosis and immune infiltration of tumor cells, and enhance antitumor immunity in platinum-based chemotherapy drug treatment. This evidence concerns the gene CXCL9 and neoplasm.